Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eye Cancer, Intraocular Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02768766
What this trial is testing

Intermittent Selumetinib for Uveal Melanoma

Who this might be right for
Uveal Melanoma
Shaheer A. Khan 42
Early research (Phase 1)Study completedNCT01430416
What this trial is testing

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

Who this might be right for
Uveal Melanoma
Novartis Pharmaceuticals 153
Not applicableUnknownNCT06073548
What this trial is testing

Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study

Who this might be right for
Uveal Melanoma
Institut Curie 250
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Testing effectiveness (Phase 2)Looking for participantsNCT03947385
What this trial is testing

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Who this might be right for
Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1 more
IDEAYA Biosciences 336
Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Testing effectiveness (Phase 2)Study completedNCT02158520
What this trial is testing

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
Academic and Community Cancer Research United 24
Testing effectiveness (Phase 2)Looking for participantsNCT06414590
What this trial is testing

Neoadjuvant Tebentafusp for Uveal Melanoma

Who this might be right for
Locally Advanced Unresectable Uveal Melanoma
Thomas Jefferson University 19
Testing effectiveness (Phase 2)WithdrawnNCT04184518
What this trial is testing

Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic Cancer
Grupo Español Multidisciplinar de Melanoma
Testing effectiveness (Phase 2)Study completedNCT01200238
What this trial is testing

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

Who this might be right for
Ocular Melanoma
Dana-Farber Cancer Institute 17
Early research (Phase 1)Ended earlyNCT02601378
What this trial is testing

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

Who this might be right for
Uveal Melanoma
Novartis Pharmaceuticals 107
Not applicableUnknownNCT02909517
What this trial is testing

The Role of Inflammation in Ocular Tumours

Who this might be right for
Ocular Melanoma
Unity Health Toronto 30
Early research (Phase 1)Study completedNCT04463368
What this trial is testing

Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases

Who this might be right for
Uveal MelanomaLiver Metastases
Vastra Gotaland Region 18
Not applicableEnrolling By InvitationNCT07338968
What this trial is testing

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

Who this might be right for
Choroidal MelanomaIndeterminate Lesions
Aura Biosciences 100
Testing effectiveness (Phase 2)UnknownNCT02654821
What this trial is testing

Study With T-cel Receptor Gene Therapy in Metastatic Melanoma

Who this might be right for
Stage IV Skin MelanomaEye; Melanoma
The Netherlands Cancer Institute 12
Early research (Phase 1)Study completedNCT03408587
What this trial is testing

CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)

Who this might be right for
Uveal MelanomaLiver Metastases
Viralytics 11
Testing effectiveness (Phase 2)Study completedNCT00020475
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04879017
What this trial is testing

FHD-286 in Subjects With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Foghorn Therapeutics Inc. 76
Next Page